US3361306A
(en)
*
|
1966-03-31 |
1968-01-02 |
Merck & Co Inc |
Aerosol unit dispensing uniform amounts of a medically active ingredient
|
US3622053A
(en)
*
|
1969-12-10 |
1971-11-23 |
Schering Corp |
Aerosol inhaler with flip-up nozzle
|
MX3864E
(es)
|
1975-05-27 |
1981-08-26 |
Syntex Corp |
Un proceso para prepara el compuesto cristalino 6-fluiro-11b 21-dihiroxi-16 17-isopropilidendioxipregna-1 4-dien-3 20-diona
|
US4185100A
(en)
*
|
1976-05-13 |
1980-01-22 |
Johnson & Johnson |
Topical anti-inflammatory drug therapy
|
US4499108A
(en)
*
|
1983-06-08 |
1985-02-12 |
Schering Corporation |
Stable pleasant-tasting albuterol sulfate pharmaceutical formulations
|
GB8334494D0
(en)
*
|
1983-12-24 |
1984-02-01 |
Tanabe Seiyaku Co |
Carbostyril derivatives
|
IT1196142B
(it)
*
|
1984-06-11 |
1988-11-10 |
Sicor Spa |
Procedimento per la preparazione di 16,17-acetali di derivati pregnanici e nuovi composti ottenuti
|
US4584320A
(en)
*
|
1985-01-03 |
1986-04-22 |
David Rubin |
Anti-asthmatic composition and method using 8,11,14,17-eicosatetraenoic acid
|
US5192528A
(en)
*
|
1985-05-22 |
1993-03-09 |
Liposome Technology, Inc. |
Corticosteroid inhalation treatment method
|
GB8828477D0
(en)
|
1988-12-06 |
1989-01-05 |
Riker Laboratories Inc |
Medical aerosol formulations
|
US5225183A
(en)
*
|
1988-12-06 |
1993-07-06 |
Riker Laboratories, Inc. |
Medicinal aerosol formulations
|
US5006343A
(en)
*
|
1988-12-29 |
1991-04-09 |
Benson Bradley J |
Pulmonary administration of pharmaceutically active substances
|
IL97065A
(en)
|
1990-02-02 |
1994-01-25 |
Fisons Plc |
Repellent preparations for aerosol
|
EP0563048A1
(en)
|
1990-12-19 |
1993-10-06 |
Smithkline Beecham Corporation |
Aerosol formulations
|
US6006745A
(en)
*
|
1990-12-21 |
1999-12-28 |
Minnesota Mining And Manufacturing Company |
Device for delivering an aerosol
|
US5190029A
(en)
*
|
1991-02-14 |
1993-03-02 |
Virginia Commonwealth University |
Formulation for delivery of drugs by metered dose inhalers with reduced or no chlorofluorocarbon content
|
EP0504112A3
(en)
|
1991-03-14 |
1993-04-21 |
Ciba-Geigy Ag |
Pharmaceutical aerosol formulations
|
WO1992020391A1
(en)
|
1991-05-21 |
1992-11-26 |
Abbott Laboratories |
Aerosol inhalation device
|
EP0601036B1
(de)
*
|
1991-08-29 |
1999-04-28 |
Broncho-Air Medizintechnik AG |
Medizinisches gerät zur inhalation von dosier-aerosolen
|
NZ244439A
(en)
|
1991-09-25 |
1994-01-26 |
Fisons Plc |
Pressurised aerosol compositions comprising hydrofluoroalkane, dispersed
|
IL104068A
(en)
|
1991-12-12 |
1998-10-30 |
Glaxo Group Ltd |
Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
|
NZ246421A
(en)
|
1991-12-18 |
1996-05-28 |
Minnesota Mining & Mfg |
Aerosol formulation containing a drug and a propellant and which is substantially free of surfactant
|
DE4230876A1
(de)
|
1992-03-17 |
1993-09-23 |
Asta Medica Ag |
Druckgaspackungen unter verwendung von polyoxyethylen-glyceryl-oleaten
|
AU6048694A
(en)
*
|
1992-12-09 |
1994-07-04 |
Paul D. Jager |
Stabilized medicinal aerosol solution formulations
|
SE9203743D0
(sv)
*
|
1992-12-11 |
1992-12-11 |
Astra Ab |
Efficient use
|
AU4066693A
(en)
|
1992-12-23 |
1994-07-19 |
Bernhard Hugemann |
Compacted drug body for use in the mechanical generation of inhalable active-substance particles
|
ES2122261T3
(es)
|
1993-03-17 |
1998-12-16 |
Minnesota Mining & Mfg |
Formulacion de aerosol que contiene un adyuvante de dispersion derivado de un ester, una amida o un mercaptoester.
|
WO1994021228A1
(en)
|
1993-03-17 |
1994-09-29 |
Minnesota Mining And Manufacturing Company |
Aerosol formulation containing a diol-diacid derived dispersing aid
|
US6596260B1
(en)
|
1993-08-27 |
2003-07-22 |
Novartis Corporation |
Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol
|
EP0735884B1
(en)
|
1993-12-20 |
2000-04-26 |
Minnesota Mining And Manufacturing Company |
Flunisolide aerosol formulations
|
US5508269A
(en)
*
|
1994-10-19 |
1996-04-16 |
Pathogenesis Corporation |
Aminoglycoside formulation for aerosolization
|
GB9425160D0
(en)
|
1994-12-10 |
1995-02-08 |
Glaxo Group Ltd |
Medicaments
|
CN1088580C
(zh)
|
1994-12-22 |
2002-08-07 |
阿斯特拉公司 |
气溶胶药物制剂
|
GB9426252D0
(en)
|
1994-12-24 |
1995-02-22 |
Glaxo Group Ltd |
Pharmaceutical composition
|
DE4446891A1
(de)
|
1994-12-27 |
1996-07-04 |
Falk Pharma Gmbh |
Stabile wäßrige Budesonid-Lösung
|
US5653961A
(en)
*
|
1995-03-31 |
1997-08-05 |
Minnesota Mining And Manufacturing Company |
Butixocort aerosol formulations in hydrofluorocarbon propellant
|
EP1166811B1
(en)
*
|
1995-04-14 |
2006-12-06 |
SmithKline Beecham Corporation |
Metered dose inhaler for fluticasone propionate
|
GEP20002266B
(en)
*
|
1995-04-14 |
2000-10-25 |
Glaxo Wellcome Inc |
Metered Dose Inhaler, the Inhaler System Comprising the Same and Method for Treatment of Respiratory Disturbances
|
DK0820279T3
(da)
*
|
1995-04-14 |
2002-10-07 |
Smithkline Beecham Corp |
Dosisudmålende inhalator til Albuterol
|
WO1996032150A1
(en)
|
1995-04-14 |
1996-10-17 |
Glaxo Wellcome Inc. |
Metered dose inhaler for salmeterol
|
GB9612297D0
(en)
|
1996-06-11 |
1996-08-14 |
Minnesota Mining & Mfg |
Medicinal aerosol formulations
|
EP0914143A1
(en)
|
1996-07-08 |
1999-05-12 |
Rhone-Poulenc Rorer Limited |
Medicinal cyclosporin-a aerosol solution formulation
|
WO1998003533A1
(en)
|
1996-07-24 |
1998-01-29 |
Oligos Etc. And Oligos Therapeutics, Inc. |
Antisense oligonucleotides as antibacterial agents
|
GB9616237D0
(en)
|
1996-08-01 |
1996-09-11 |
Norton Healthcare Ltd |
Aerosol formulations
|
GB9620187D0
(en)
|
1996-09-27 |
1996-11-13 |
Minnesota Mining & Mfg |
Medicinal aerosol formulations
|
US6413496B1
(en)
*
|
1996-12-04 |
2002-07-02 |
Biogland Ireland (R&D) Limited |
Pharmaceutical compositions and devices for their administration
|
AU726510B2
(en)
|
1996-12-04 |
2000-11-09 |
Consort Medical Plc |
Pharmaceutical compositions and devices for their administration
|
DK1014943T3
(da)
|
1997-02-05 |
2002-10-14 |
Jago Res Ag |
Medicinske aerosolformuleringer
|
US6126919A
(en)
|
1997-02-07 |
2000-10-03 |
3M Innovative Properties Company |
Biocompatible compounds for pharmaceutical drug delivery systems
|
US5891419A
(en)
*
|
1997-04-21 |
1999-04-06 |
Aeropharm Technology Limited |
Environmentally safe flunisolide aerosol formulations for oral inhalation
|
GB2326334A
(en)
|
1997-06-13 |
1998-12-23 |
Chiesi Farma Spa |
Pharmaceutical aerosol compositions
|
US20010031244A1
(en)
*
|
1997-06-13 |
2001-10-18 |
Chiesi Farmaceutici S.P.A. |
Pharmaceutical aerosol composition
|
BR7702049U
(pt)
|
1997-09-05 |
1999-09-14 |
Chiesi Farma Spa |
Bico pulverizador para utilização em inalador oral para medicamentos aerossóis
|
US5954047A
(en)
*
|
1997-10-17 |
1999-09-21 |
Systemic Pulmonary Development, Ltd. |
Methods and apparatus for delivering aerosolized medication
|
US6045784A
(en)
*
|
1998-05-07 |
2000-04-04 |
The Procter & Gamble Company |
Aerosol package compositions containing fluorinated hydrocarbon propellants
|
SE9802073D0
(sv)
|
1998-06-11 |
1998-06-11 |
Astra Ab |
New use
|
US6451285B2
(en)
*
|
1998-06-19 |
2002-09-17 |
Baker Norton Pharmaceuticals, Inc. |
Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
|
US6241969B1
(en)
*
|
1998-06-26 |
2001-06-05 |
Elan Corporation Plc |
Aqueous compositions containing corticosteroids for nasal and pulmonary delivery
|
DE19847969A1
(de)
*
|
1998-10-17 |
2000-04-20 |
Boehringer Ingelheim Pharma |
Lagerfähig flüssige Formulierung mit Formoterol
|
DK1283036T3
(da)
*
|
1998-11-13 |
2008-03-25 |
Jagotec Ag |
Törpulver til inhalation
|
DZ2947A1
(fr)
*
|
1998-11-25 |
2004-03-15 |
Chiesi Farma Spa |
Inhalateur à compteur de dose sous pression.
|
IT1303788B1
(it)
*
|
1998-11-25 |
2001-02-23 |
Chiesi Farma Spa |
Formulazioni di aerosol medicinali.
|
US6004537A
(en)
*
|
1998-12-18 |
1999-12-21 |
Baker Norton Pharmaceuticals, Inc. |
Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
|
US6290930B1
(en)
*
|
1998-12-18 |
2001-09-18 |
Baker Norton Pharmaceuticals, Inc. |
Pharmaceutical solution aerosol formulations containing fluoroalkanes and budesonide
|
US6315985B1
(en)
*
|
1999-06-18 |
2001-11-13 |
3M Innovative Properties Company |
C-17/21 OH 20-ketosteroid solution aerosol products with enhanced chemical stability
|
IT1317846B1
(it)
*
|
2000-02-22 |
2003-07-15 |
Chiesi Farma Spa |
Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
|
IT1318514B1
(it)
*
|
2000-05-12 |
2003-08-27 |
Chiesi Farma Spa |
Formulazioni contenenti un farmaco glucocorticosteroide per iltrattamento di patologie broncopolmonari.
|
ME00220B
(me)
|
2000-05-22 |
2010-10-10 |
Chiesi Farm Spa |
Stabilne farmaceutske formulacije rastvora za inhalatore odmjerene doze pod pritiskom
|
TR200401980T4
(tr)
*
|
2001-07-02 |
2004-09-21 |
Chiesi Farmaceutici S.P.A. |
Aerosol olarak uygulama için en uygun hale getirilmiş tobramisin formülasyonu
|
PT3494995T
(pt)
*
|
2002-03-01 |
2020-03-30 |
Chiesi Farm Spa |
Formulação superfina de formoterol
|
EP1415647A1
(en)
*
|
2002-10-23 |
2004-05-06 |
CHIESI FARMACEUTICI S.p.A. |
"Long-acting beta-2 agonists ultrafine formulations"
|
EP1340492A1
(en)
*
|
2002-03-01 |
2003-09-03 |
CHIESI FARMACEUTICI S.p.A. |
Aerosol formulations for pulmonary administration of medicaments having systemic effects
|
US20050083693A1
(en)
*
|
2003-10-21 |
2005-04-21 |
Timothy Garrett |
Flag illumination fixture
|